Invenomic Capital Management’s Metallus MTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-697,815
Closed -$10.8M 186
2025
Q2
$10.8M Buy
697,815
+46,542
+7% +$620K 0.61% 61
2025
Q1
$8.7M Buy
+651,273
New +$9.47M 0.44% 83
2022
Q1
Sell
-106,264
Closed -$1.75M 185
2021
Q4
$1.75M Sell
106,264
-75,893
-42% -$1.11M 0.37% 80
2021
Q3
$2.38M Buy
182,157
+78,349
+75% +$1.07M 0.77% 45
2021
Q2
$1.47M Sell
103,808
-92,958
-47% -$1.26M 0.35% 62
2021
Q1
$2.31M Buy
+196,766
New +$1.47M 0.52% 39

Other funds holding MTUS

Invenomic Capital Management's MTUS Position: Q3 2025 in Review

Invenomic Capital Management sold out of Metallus (MTUS) in Q3 2025, closing a stake of 697,815 shares — an estimated $10.8M sold.

Invenomic Capital Management first reported a position in MTUS in Q1 2021 and held it in 6 quarters. The position peaked at $10.8M in Q2 2025. 195 funds tracked by Wall St. Rank hold MTUS as of Q3 2025.

  • Invenomic Capital Management reported no remaining Metallus position as of Q3 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 697,815 Metallus shares in Q3 2025, an estimated $10.8M.
  • Invenomic Capital Management first reported a position in Metallus in Q1 2021 and held it in 6 quarters.
  • Invenomic Capital Management's Metallus position peaked at $10.8M in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Metallus as of Q3 2025.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.